-
Mix and Match vaccine highly effective against Covid-19
They said that the risk reduction was 50 for people having received two doses of the AstraZeneca vaccine which is known as Covishield in India
-
Antibody therapy from AstraZeneca prevents Covid-19: Study
AstraZeneca has become the first company to publish positive Covid prevention data from an antibody trial
-
Pfizer and AstraZeneca less effective against Delta variant
Delta infections after two vaccine doses had similar peak levels of virus as those in unvaccinated people, the researchers said
-
SEC panel approves trial of Covaxin-nasal vaccine mix
Bharat Biotech will be mixing Covaxin, which is administered intramuscularly, with a nasal inoculation based on a different vector.
-
Anathema towards Covishield must go
To emerge out of this dark period, the world needs to become more inclusive
-
AstraZeneca Covid vaccine produces stronger immune response with an 11-month gap: Study
With a 45-week dosing interval between the first and second dose, antibody levels were four times higher than with a 12-week interval.
-
Pfizer, AstraZeneca vaccines protect against Delta variant: Lancet study
Pfizer vaccine offered 92% protection against the Alpha variant and 79% against the Delta strain two weeks after the second dose.
-
WTO inches forward in Covid vaccine patent waiver talks
Since October, the WTO has faced calls led by India and South Africa for the temporary removal of such intellectual property protections
-
WTO inches forward in Covid vaccine patent waiver talks
WTO has struggled to move forward on the issue since all decisions at the global trade body must be reached by consensus of all 164 member states
-
Covid-19: Vietnam finds new virus variant, hybrid of India, UK strains
Viruses often develop small genetic changes as they reproduce, and new variants of the coronavirus have been seen almost since it was first detected i
